HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Modulation of allergic response in nasal mucosa by antisense oligodeoxynucleotides for IL-4.

AbstractBACKGROUND:
The cytokine IL-4 is highly involved in T(H)2 inflammation, such as that seen in allergic rhinitis. IL-4 can induce IgE synthesis and eotaxin. Recent studies have shown that stimulation of allergic nasal tissue with ragweed allergen can induce local IL-4 mRNA production.
OBJECTIVE:
We set out to determine whether IL-4 antisense phosphorothioate-modified oligodeoxynucleotides (PS-ODNs) could inhibit IL-4 production and downstream events of IL-4.
METHODS:
Nasal mucosa biopsy specimens were obtained from patients with seasonal ragweed allergic rhinitis out of season, incubated ex vivo with or without PS-ODNs, and challenged with ragweed. FITC-labeled oligonucleotides were used to determine tissue uptake. By using immunocytochemistry, IL-4-, IL-13-, eotaxin 1-, and IFN-gamma-producing cells were enumerated, and by using in situ hybridization, epsilon germline transcript RNA- and IL-4 mRNA-positive cells were examined.
RESULTS:
The antisense PS-ODN was taken up by the tissue, and preincubation of the tissue with the IL-4 antisense PS-ODN caused a decrease in allergen-induced IL-4 mRNA and a decrease in the amount of IL-4 immunoreactivity (n = 7, P <.001). PS-ODNs had inhibitory effects on allergen-induced epsilon germline transcript RNA expression (n = 7, P <.001) and mucosa eotaxin 1 immunoreactivity (n = 7, P <.05). In contrast, the PS-ODNs increased the amount of IFN-gamma immunoreactivity (n = 7, P <.05), suggesting a nonspecific mechanism for reduced synthesis of IgE and eotaxin.
CONCLUSIONS:
Our results show that the IL-4 antisense PS-ODN effectively inhibits IL-4, IgE synthesis, and eotaxin, principal mediators of allergic inflammation, suggesting that PS-ODNs might offer a possible topical treatment for allergic rhinitis.
AuthorsPierre-Olivier Fiset, Abdelilah Soussi-Gounni, Pota Christodoulopoulos, Meri Tulic, Steven E Sobol, Saul Frenkiel, François Lavigne, Bouchaib Lamkhioued, Qutayba Hamid
JournalThe Journal of allergy and clinical immunology (J Allergy Clin Immunol) Vol. 111 Issue 3 Pg. 580-6 (Mar 2003) ISSN: 0091-6749 [Print] United States
PMID12642840 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Allergens
  • CCL11 protein, human
  • Chemokine CCL11
  • Chemokines, CC
  • Oligonucleotides, Antisense
  • Protein Isoforms
  • RNA, Messenger
  • Thionucleotides
  • Interleukin-4
  • Immunoglobulin E
  • Interferon-gamma
Topics
  • Allergens (immunology)
  • Chemokine CCL11
  • Chemokines, CC (antagonists & inhibitors)
  • Humans
  • Hypersensitivity (physiopathology)
  • Immunoglobulin E (genetics)
  • Interferon-gamma (metabolism)
  • Interleukin-4 (antagonists & inhibitors, genetics)
  • Nasal Mucosa (drug effects, physiopathology)
  • Oligonucleotides, Antisense (pharmacology)
  • Protein Isoforms (genetics)
  • RNA, Messenger (antagonists & inhibitors, biosynthesis)
  • Thionucleotides (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: